FDA’s Richard Pazdur Cares Little for the Scientific Process and the Needs of Desperate Patients
prostate cancer blog wrote an interesting post today on
Here’s a quick excerpt
There was ample of evidence of survival benefit conferred by Provenge as a treatment in contrast to Dr. Pazdur’s statement: “Believe me, if there were a clear survival effect, the drug would be approved,”. In fact, Dr. Pazdur’s focus on the statistical flaws showed that the main problem in the FDA drug approval process as practiced by Dr. Pazdur is a slavish following of rigid statistical rules without properly factoring in clinical knowledge required to give meaning to such numerical data. Th
Read the rest of this great post here